Corsair Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding HBIO
WCM
MIM
NCNMGF
MBAM
Corsair Capital Management's HBIO Position: Q2 2026 in Review
Corsair Capital Management reduced its Harvard Bioscience (HBIO) stake by 1.6% in Q2 2026, selling an estimated $12K and leaving 122,810 shares worth $755K. The position accounts for 0.09% of the portfolio, ranked #84.
Corsair Capital Management first reported a position in HBIO in Q4 2023 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.
- Corsair Capital Management held 122,810 shares of Harvard Bioscience worth $755K as of Q2 2026.
- Corsair Capital Management sold 2,000 Harvard Bioscience shares in Q2 2026, an estimated $12K.
- Harvard Bioscience made up 0.09% of Corsair Capital Management's portfolio in Q2 2026, its #84 holding.
- Corsair Capital Management first reported a position in Harvard Bioscience in Q4 2023 and has held it in 6 quarters since.
- 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.
Based on Corsair Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.